Skip to main content

Table 2 Selected SLC2A9 SNPs in relation to the risk of Parkinson’s disease*

From: Short communication: genetic variations of SLC2A9 in relation to Parkinson’s disease

  All   Men   Women
SNPs MAF OR (95% CI) P MAF OR (95% CI) P MAF OR (95% CI) P
  Case Control    Case Control    Case Control   
rs16890979 0.23 0.22 1.06 (0.90-1.24) 0.51 0.22 0.23 0.99 (0.82-1.19) 0.92 0.23 0.18 1.40 (0.96-2.03) 0.08
rs13129697 0.26 0.27 0.99 (0.85-1.16) 0.91 0.26 0.27 0.95 (0.79-1.13) 0.53 0.28 0.24 1.19 (0.84-1.69) 0.33
rs737267 0.25 0.25 1.01 (0.86-1.18) 0.91 0.25 0.25 0.97 (0.81-1.16) 0.70 0.25 0.22 1.20 (0.85-1.70) 0.30
rs6855911 0.25 0.25 1.00 (0.85-1.18) 0.98 0.24 0.25 0.95 (0.80-1.14) 0.61 0.25 0.22 1.21 (0.85-1.71) 0.29
rs4697700 0.24 0.23 1.03 (0.88-1.22) 0.69 0.24 0.24 1.02 (0.85-1.22) 0.87 0.23 0.21 1.13 (0.79-1.62) 0.49
rs4481233 0.19 0.19 1.01 (0.85-1.21) 0.90 0.19 0.20 0.96 (0.79-1.18) 0.72 0.19 0.16 1.25 (0.84-1.87) 0.28
rs7442295 0.22 0.21 1.06 (0.90-1.26) 0.50 0.22 0.22 0.98 (0.81-1.19) 0.83 0.23 0.17 1.48 (1.01-2.16) 0.04
rs6449213 0.19 0.19 1.01 (0.85-1.21) 0.88 0.20 0.20 0.97 (0.79-1.18) 0.74 0.19 0.16 1.23 (0.83-1.84) 0.31
rs1014290 0.25 0.25 1.04 (0.88-1.22) 0.67 0.26 0.25 1.07 (0.89-1.28) 0.48 0.23 0.24 0.91 (0.63-1.31) 0.62
rs12509955 0.21 0.22 0.99 (0.84-1.18) 0.93 0.22 0.22 1.00 (0.82-1.20) 0.96 0.19 0.20 0.99 (0.67-1.46) 0.95
rs17251963 0.21 0.20 1.05 (0.88-1.25) 0.59 0.21 0.20 1.02 (0.84-1.24) 0.83 0.20 0.18 1.17 (0.78-1.75) 0.44
rs12510549 0.21 0.22 0.96 (0.81-1.14) 0.65 0.21 0.23 0.91 (0.76-1.10) 0.34 0.20 0.18 1.22 (0.83-1.79) 0.31
  1. * Odds ratios and 95% confidence intervals were derived from logistic regression models under the assumption of logit-additive allelic effects, adjusting for age, sex, smoking status and caffeine intake.
  2. MAF: minor allele frequency; OR: odds ratio; CI: confidence intervals.